160 related articles for article (PubMed ID: 34575906)
1. A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ.
Bolcato G; Cescon E; Pavan M; Bissaro M; Bassani D; Federico S; Spalluto G; Sturlese M; Moro S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575906
[TBL] [Abstract][Full Text] [Related]
2. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
[TBL] [Abstract][Full Text] [Related]
3. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
[TBL] [Abstract][Full Text] [Related]
6. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
7. Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study.
Pavan M; Menin S; Bassani D; Sturlese M; Moro S
Front Mol Biosci; 2022; 9():909499. PubMed ID: 35874609
[TBL] [Abstract][Full Text] [Related]
8. Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines.
Park H; Jung HY; Mah S; Kim K; Hong S
Org Biomol Chem; 2020 Oct; 18(41):8402-8413. PubMed ID: 33112339
[TBL] [Abstract][Full Text] [Related]
9. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
[TBL] [Abstract][Full Text] [Related]
10. Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?
Bissaro M; Federico S; Salmaso V; Sturlese M; Spalluto G; Moro S
ChemMedChem; 2018 Dec; 13(24):2601-2605. PubMed ID: 30359484
[TBL] [Abstract][Full Text] [Related]
11. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
12. Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents.
Joshi K; Goyal S; Grover S; Jamal S; Singh A; Dhar P; Grover A
BMC Bioinformatics; 2016 Dec; 17(Suppl 19):515. PubMed ID: 28155653
[TBL] [Abstract][Full Text] [Related]
13. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
[TBL] [Abstract][Full Text] [Related]
14. Ligand-protein interactions of selective casein kinase 1δ inhibitors.
Mente S; Arnold E; Butler T; Chakrapani S; Chandrasekaran R; Cherry K; DiRico K; Doran A; Fisher K; Galatsis P; Green M; Hayward M; Humphrey J; Knafels J; Li J; Liu S; Marconi M; McDonald S; Ohren J; Paradis V; Sneed B; Walton K; Wager T
J Med Chem; 2013 Sep; 56(17):6819-28. PubMed ID: 23919824
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
[TBL] [Abstract][Full Text] [Related]
16. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
Ruzic D; Djokovic N; Nikolic K
Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.
Long A; Zhao H; Huang X
J Med Chem; 2012 Jan; 55(2):956-60. PubMed ID: 22168824
[TBL] [Abstract][Full Text] [Related]
18. Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity.
Kumar A; Rajendran V; Sethumadhavan R; Purohit R
J Biomol Struct Dyn; 2014; 32(3):394-405. PubMed ID: 23527964
[TBL] [Abstract][Full Text] [Related]
19. CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP.
Roth A; Gärtner F; Mayer K; Beyrle J; König I; Knippschild U; Bischof J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203978
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
